Biogen has secured US FDA approval for a high dose Spinraza regimen for spinal muscular atrophy. Viridian Therapeutics has...
Read MoreDNA Script is expanding access to its SYNTAX platform across Latin America, South Korea and Japan through new distribution...
Read MoreArvinas has reported encouraging phase 1 data for ARV-102, an investigational PROTAC degrader for Parkinson’s disease. R1 Therapeutics has...
Read MoreMHRA has approved deuruxolitinib, marketed as Leqselvi, for adults with severe alopecia areata, adding a new prescription treatment option...
Read MoreKatalyze Data and SAS have developed DementAI, a UK-built artificial intelligence system designed to help identify Alzheimer’s disease risk...
Read MoreMHRA has approved imlunestrant tosylate (Inluriyo) for a defined group of adults with ER-positive, HER2-negative locally advanced or metastatic...
Read More